Peng Jiang
@pengjiang20
NIH Stadtman Investigator @ NCI Cancer Data Science Lab
All views are my own and do not represent NIH/NCI.
ID: 1148976717098176513
https://scholar.google.com/citations?user=Dafi6DsAAAAJ&hl=en&oi=ao 10-07-2019 15:26:11
40 Tweet
484 Followers
147 Following
Gene signatures associated with T cell resilience to tumor-derived immunosuppressive signals predict responses to immune checkpoint inhibitors and adoptive cell therapy, and identify FIBP as a negative regulator of T cell activity Peng Jiang National Cancer Institute nature.com/articles/s4159…
Thank you to Cancer Discovery Cancer Discovery for highlighting our recent work. doi.org/10.1158/2159-8…
Our review paper on Big data applications in Cancer is online at Nature Reviews Cancer Nature Reviews Cancer: rdcu.be/cUZSR. reflecting joint insights from our colleagues (@NCIEytanRuppin @NCIKenAldape Sridhar Hannenhalli Cenk Sahinalp & Team Sanju Sinha)
Recently published: Beibei RU Peng Jiang @NCIEytanRuppin develop Spatial Cellular Estimator for Tumors (SpaCET) to infer cell types and ligand-receptor interactions from #SpatialTranscriptomics data in cancer #CancerResearch Cancer at Nature Portfolio doi.org/10.1038/s41467…
With a mixed bag of emotions - nervousness, excitement, fear & determination, I am announcing the start of my lab at Sanford Burnham Prebys, San Diego. Our focus will be to develop new preventative therapies for cancer using machine learning.